Navigation Links
Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting

Commenting on these pre-clinical results, Dr. Eissner stated, "Our in vivo and in vitro data suggest that while Defibrotide is known for its anti-inflammatory and endothelium-protecting function, it also inhibits (tumor) blood vessel formation. This concept is supported by RT-PCR data showing that Defibrotide significantly down-regulates heparanase expression in endothelial and tumor cells, and thus should be considered for further testing as an anticancer agent."

Laura Ferro, M.D., Gentium's president and chief executive officer, said, "These pre-clinical results are very encouraging and continue to expand our scientific knowledge of Defibrotide's multi-factorial mechanisms of action and help us to better understand its therapeutic value as a potentially powerful anticancer agent.

"We are especially pleased with the data presented at AACR as it further elucidates Defibrotide's mechanism of action and corroborates positive preliminary data from an independent Phase I/II study of Defibrotide to treat multiple myeloma in combination with melphalan, prednisone and thalidomide underway in Italy."

About Gentium

Gentium, S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the research, discovery and development of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Orphan Drug status and Fast Track Designation by the U.S. Food and Drug Administration to treat Severe Veno-occlusive disease (VOD) and Orphan Medicinal Product Designation by the European Commission both to treat and to prevent VOD.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements." In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expect," "plan," "anticipate,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Gentiums Defibrotide Seen as Active in Multiple Myeloma
2. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
3. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
4. Isotechnikas Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
7. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
8. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
9. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
Post Your Comments:
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) ... report "Drug Delivery in Central Nervous System ... their offering. The delivery of drugs ... in the treatment of neurological disorders. Drugs may ... systematically (e.g., by intravenous injection) for targeted action ...
(Date:6/2/2015)... June 2, 2015 The Canadian Society for Vascular ... tests, treatments or procedures that are commonly ordered ... part of Choosing Wisely Canada.  The list identifies ... conversations between patients and physicians about what care ... for Vascular Surgery,s list identified the following five ...
(Date:6/2/2015)... , June 02, 2015 Research and Markets ( ... Archiving and Communication Systems (PACS) - Global Strategic Business Report" ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... and forecasts are provided for the period 2014 through 2020. ...
Breaking Medicine Technology:Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
... Bend Research Inc. ( www.bendresearch.com ), a leading independent ... McLeod has joined the company as Chief Financial Officer. ... McLeod was formerly Director of Business Development with ... strategic vision is credited with improving many different parts ...
... 2011 Comprehensive Care Corporation (OTC BB: CHCR), which ... services for managed care companies throughout the U.S., today ... been praised by the Chamber of Commerce of the ... Advisory Council in "helping to shape and drive the ...
Cached Medicine Technology:Bend Research Announces New Chief Financial Officer 2Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service 2
(Date:6/2/2015)... The Down Syndrome Association of Wisconsin (DSAW) is ... Glee as the keynote speaker for its June 6, ... The event aims to raise funds to support programs ... counties. , "We couldn't be more ... event," says Dawn Nuoffer, DSAW Executive Director. "She's a ...
(Date:6/2/2015)... New Jersey (PRWEB) June 02, 2015 ... (Horizon BCBSNJ) announced today that its Walking and Wellness ... Classic Presented by Acer, has raised another $3,000 for ... Natalie Gulbis undertook the challenge, recording 32,000 steps on ... at Stockton Seaview Hotel & Golf Club in Galloway ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “ Radaris ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... the data they need on a person. , According to ... publication even goes on to explain that curiosity is a ...
(Date:6/2/2015)... October 1, 2015 the transition to ICD-10 will happen ... Monday, June 1st Congressman Kevin Brady, chairman of ... Committee, and 12 members of the Committee sent a ... the administration to provide a smooth transition for local ... newest coding system for healthcare professionals to code diseases, ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Claflin ... distributor, has announced the acquisition of RSI ... distributor, effective May 29th, 2015. , With CME’s recent ... this latest acquisition joins three premier organizations which specialize ... hospitals and healthcare facilities. By combining forces, they now ...
Breaking Medicine News(10 mins):Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2
... , AUGUSTA, Ga. Scientists want to protect the optic nerve ... a car wreck. It,s called traumatic optic nerve damage when ... gets rattled, resulting in swelling and inflammation that can destroy its ... loss and blindness. "The optic nerve is not completely straight ...
... has named Takeo Kanade, the U.A. and Helen Whitaker ... Mellon University, the 2010 winner of the ACM/AAAI Allen ... and robotics. , The Newell Award, named for one ... Computer Science, recognizes career contributions that have breadth within ...
... lead-based ammunition as a potential health and environmental hazard, ... material for bullets tungsten may not be ... accumulates in major structures of the immune system in ... Toxicology . Jose Centeno and colleagues explain that ...
... 2011) Breast cancer is the second most common cancer ... Being exposed to estrogen over a long period of time ... developing the disease. One way a woman can combat ... tamoxifen, which interferes with the activity of estrogen. Now, ...
... not really be compatible with current beauty ideals, but, to a ... our body. However, it is a different matter if the organism ... This is a clear sign of a metabolic disorder. ... which is regarded a typical characteristic of the dangerous metabolic syndrome. ...
... , TUESDAY, April 5 (HealthDay News) -- In the ... researchers report that risks to postmenopausal women who were ... the treatment. The study found that when ... blood clots, which were elevated while they were on ...
Cached Medicine News:Health News:Better treatment sought for blinding traumatic optic nerve damage 2Health News:CMU's Takeo Kanade wins ACM/AAAI Award for career contributions to computer vision, robotics 2Health News:Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen 2Health News:Fatty liver -- how a serious problem arises 2Health News:Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends 2Health News:Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends 3
... The Stryker Threaded Dilator ... yet another choice for ... Dilators provide compaction reaming ... compaction of bone within ...
... The Arthroscopy Scissor is ideal for excising ... tissue debris in the joint. The serrated edge ... as well as hold tissue within the jaws ... left and right jaw curvatures, are the perfect ...
... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ... size and angle required for large and ...
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
Medicine Products: